Literature DB >> 22728937

Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Linda K Bockenstedt1, David G Gonzalez, Ann M Haberman, Alexia A Belperron.   

Abstract

An enigmatic feature of Lyme disease is the slow resolution of musculoskeletal symptoms that can continue after treatment, with some patients developing an inflammatory arthritis that becomes refractory to antibiotic therapy. Using intravital microscopy and the mouse model of Lyme borreliosis, we observed that Borrelia burgdorferi antigens, but not infectious spirochetes, can remain adjacent to cartilage for extended periods after antibiotic treatment. B. burgdorferi was not recovered by culture or xenodiagnosis with ticks after antibiotic treatment of WT mice and all but one of the immunodeficient mice with heightened pathogen burden due to impaired TLR responsiveness. Amorphous GFP+ deposits were visualized by intravital microscopy in the entheses of antibiotic-treated mice infected with GFP-expressing spirochetes and on the ear cartilage surface in sites where immunofluorescence staining detected spirochete antigens. Naive mice were not infected by tissue transplants from antibiotic-treated mice even though transplants contained spirochete DNA. Tissue homogenates from antibiotic-treated mice induced IgG reactive with B. burgdorferi antigens after immunization of naive mice and stimulated TNF-α production from macrophages in vitro. This is the first direct demonstration that inflammatory B. burgdorferi components can persist near cartilaginous tissue after treatment for Lyme disease. We propose that these deposits could contribute to the development of antibiotic-refractory Lyme arthritis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728937      PMCID: PMC3386809          DOI: 10.1172/JCI58813

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

Review 1.  Persister cells.

Authors:  Kim Lewis
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  The heterogeneous motility of the Lyme disease spirochete in gelatin mimics dissemination through tissue.

Authors:  Michael W Harman; Star M Dunham-Ems; Melissa J Caimano; Alexia A Belperron; Linda K Bockenstedt; Henry C Fu; Justin D Radolf; Charles W Wolgemuth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 3.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

4.  Persistence of dead-cell bacterial DNA in ex vivo root canals and influence of nucleases on DNA decay in vitro.

Authors:  Malin Brundin; David Figdor; Chrissie Roth; John K Davies; Göran Sundqvist; Ulf Sjögren
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-12

5.  Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.

Authors:  Xin Li; Gail A McHugh; Nitin Damle; Vijay K Sikand; Lisa Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2011-08

Review 6.  Multidrug tolerance of biofilms and persister cells.

Authors:  K Lewis
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks.

Authors:  Star M Dunham-Ems; Melissa J Caimano; Utpal Pal; Charles W Wolgemuth; Christian H Eggers; Anamaria Balic; Justin D Radolf
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

Review 8.  "Persisters": survival at the cellular level.

Authors:  Clinton C Dawson; Chaidan Intapa; Mary Ann Jabra-Rizk
Journal:  PLoS Pathog       Date:  2011-07-28       Impact factor: 6.823

9.  Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Authors:  Monica E Embers; Stephen W Barthold; Juan T Borda; Lisa Bowers; Lara Doyle; Emir Hodzic; Mary B Jacobs; Nicole R Hasenkampf; Dale S Martin; Sukanya Narasimhan; Kathrine M Phillippi-Falkenstein; Jeanette E Purcell; Marion S Ratterree; Mario T Philipp
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis.

Authors:  Judith Miklossy; Sandor Kasas; Anne D Zurn; Sherman McCall; Sheng Yu; Patrick L McGeer
Journal:  J Neuroinflammation       Date:  2008-09-25       Impact factor: 8.322

View more
  95 in total

1.  Remains of infection.

Authors:  Alan Barbour
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.

Authors:  Charles S Pavia; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

3.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

4.  Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis.

Authors:  Robert B Lochhead; Sheila L Arvikar; John M Aversa; Ruslan I Sadreyev; Klemen Strle; Allen C Steere
Journal:  Cell Microbiol       Date:  2018-10-17       Impact factor: 3.715

Review 5.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

6.  Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi.

Authors:  Venkata Raveendra Pothineni; Dhananjay Wagh; Mustafeez Mujtaba Babar; Mohammed Inayathullah; R Edward Watts; Kwang-Min Kim; Mansi B Parekh; Abhijit Achyut Gurjarpadhye; David Solow-Cordero; Lobat Tayebi; Jayakumar Rajadas
Journal:  J Antibiot (Tokyo)       Date:  2016-11-09       Impact factor: 2.649

7.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Authors:  Adriana Marques; Sam R Telford; Siu-Ping Turk; Erin Chung; Carla Williams; Kenneth Dardick; Peter J Krause; Christina Brandeburg; Christopher D Crowder; Heather E Carolan; Mark W Eshoo; Pamela A Shaw; Linden T Hu
Journal:  Clin Infect Dis       Date:  2014-02-11       Impact factor: 9.079

8.  Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Authors:  Klemen Strle; Daša Stupica; Elise E Drouin; Allen C Steere; Franc Strle
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

9.  Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.

Authors:  Nalini K Vudattu; Klemen Strle; Allen C Steere; Elise E Drouin
Journal:  Arthritis Rheum       Date:  2013-06

Review 10.  Review: unraveling Lyme disease.

Authors:  Linda K Bockenstedt; Gary P Wormser
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.